duit Pharmaceuticals (CDT) - 2023 Q1 - Quarterly Report

● increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; Merger Agreement In connection with the transactions contemplated by the Merger Agreement, we entered into a subscription agreement (the "Subscription Agreement") with an investor. Pursuant to the Subscription Agreement, the investor has agreed to purchase $27 million (the "Private Placement") units of our securities, with each unit consisting of (i) one share o ...